Evaluation of Robotic-assisted Mitral Surgery With the daVinci X Surgical System
Study Details
Study Description
Brief Summary
Robotic assistance allows performance of mitral valve operations with a truly minimally invasive and totally thoracoscopic approach, with significant advantages for patients compared to sternotomy-based surgery. Nonetheless, its diffusion has been limited by: 1) significant learning curve and technical requirements; 2) increased immediate financial costs due to dedicated equipment and materials. The aim of the present study is to perform a prospective data collection and evaluation of the in-hospital and follow-up clinical results of mitral valve repair using the last generation DaVinci X robotic platform. A cost-effectiveness analysis of this approach will be also conducted, under a global healthcare system perspective (including the overall patients' pathway starting from diagnosis of mitral valve disease until the completion of the 1st postoperative year). Since the 'competitor' surgical technique is not represented by sternotomy-based mitral surgery, but instead by minimally invasive, video-assisted mitral surgery, patients operated on using such technique will serve as controls.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
In an observational, prospective, case-control investigation, the clinical data of all adult (18 years-old or more) patients undergoing robotic-assisted mitral surgery in the Sponsor hospital during the study period will be collected, including preoperative, intraoperative and early postoperative variables. Patients need to be affected by severe mitral regurgitation due to degenerative lesions and be eligible to robotic-assisted surgery. An informed consent for inclusion in the study and management of personal data will be asked from all participants. A total of 30 Baseline variables, 9 intraoperative variables, 26 early postoperative variables and 55 follow-up variables will be collected. Systematic in-house follow-up (clinical and echocardiographic) will be performed at the 3rd, 6th and 12th postoperative months. The database will be managed by research assistants under the supervision of the surgical team. Operations will be performed according to the Institutional protocol using the DaVinci X robotic platform by a trained multidisciplinary team including cardiac surgeons, anesthesiologists, cardiologists, perfusionists and scrub nurses.
The same data will be obtained for all patients undergoing minimally invasive, video-assisted non-robotic-assisted mitral repair during the study period. These patients will serve as controls.
Study Endpoints will include procedural success, early postoperative complications, postoperative functional recovery (both immediate and at follow-up), echocardiographic results of mitral repair.
Such data will be compared with those from control patients undergoing minimally invasive, non-robotic-assisted mitral surgery in our Department during the study period.
In cooperation with Hospital Administration Team, all direct and indirect costs (Euros) associated with the in-hospital pathway of each individual patient will be quantified (17 variables per patient within a separate database). Data collection will be expanded to any hospitalisation occurring during the 1st postoperative year. Such data collection will include patients undergoing both the robotic-assisted and the minimally invasive video-assisted non-robotic-assisted strategy.
Data will be analysed using intergoup comparison statistical tests.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Robotic-assisted Group
|
Device: Robotic-assisted mitral valve repair
Mitral valve repair using robotic technology (DaVinci X platform)
|
| Video-assisted Group
|
Outcome Measures
Primary Outcome Measures
- Duration of ICU stay (hours) and Hospital stay (days and hours) [Up to 30 days after index surgery.]
Duration of stay inside healthcare facility providing index operation. Average value and standard deviation will be presented.
- Rate of Major Adverse Cerebral and Cardiovascular Events (MACCE) [Day of index surgery until 30th postoperative day or discharge]
Rate of stroke/TIA, myocardial infarction, cardiac reoperation (presented through both individual and aggregated rates).
- Economic evaluation (direct and indirect costs). [Up to 90 days after index surgery.]
Direct and indirect costs associated with robotic-assisted mitral surgery. These will be evaluated for each individual patient and expressed in Euros, under the form of average value and standard deviation. Direct costs will be categorized as follows: total supplies, total drugs, unit operating costs, unit supporting costs).
Secondary Outcome Measures
- Rate of residual mitral regurgitation (Early). [Up to 60 days after index surgery.]
Data will be obtained from pre-discharge echocardiography. Residual Mitral Regurgitation is defined as being at least of degree 2+/4+ according to current Echocardiography recommendations.
- Rate of residual mitral regurgitation (follow-up). [From the 3rd until the 12th month after index surgery.]
Data will be obtained from echocardiography performed at the 3rd, 6th and 12th postoperative months. Residual Mitral Regurgitation is defined as being at least of degree 2+/4+ according to current Echocardiography recommendations.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged at least 18, willing to complete the study follow-up, having signed the informed consent for participation and data management.
-
Severe mitral regurgitation due to degenerative disease with indication to mitral repair surgery.
-
If of female gender, being neither pregnant nor lactating.
Exclusion Criteria:
-
Previous right chest surgery or severe right intrapleural adhesions.
-
Diameter of femoral arteries equal or lesser than 6 mm.
-
Left ventricular systolic dysfunction (LVEF <60%).
-
Severe right ventricular dysfunction.
-
Aortic valve regurgitation >1+/4+.
-
Pulmonary artery hypertension (PASP >50 mmHg).
-
Chest deformities preventing either robotic-assisted or minimally invasive video-assisted surgery.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cliniche HUMANITAS Gavazzeni | Bergamo | Italy | 24125 |
Sponsors and Collaborators
- Cliniche Humanitas Gavazzeni
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GAV 213/20